Plasticity of lineage switch in B-ALL allows for successful rechallenge with CD19-directed immunotherapy
Brittany M. Lee, Corinne Summers, Karen M. Chisholm, Sandra D. Bohling, Kasey J. Leger, Rebecca Gardner, Colleen Annesley, Adam J. Lamble
Topics & Concepts
CD19ImmunotherapyLineage (genetic)ImmunologyMedicineBiologyAntigenGeneticsImmune systemGeneCAR-T cell therapy researchAcute Lymphoblastic Leukemia researchChronic Myeloid Leukemia Treatments